CS
LUNG icon

Credit Suisse’s Pulmonx LUNG Stock Holding History

Credit Suisse’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$446K Buy
48,127
+2,331
+5% +$27.3K ﹤0.01% 2684
2023
Q4 		$584K Buy
45,796
+1,422
+3% +$14.8K ﹤0.01% 2653
2023
Q3 		$458K Buy
44,374
+8,980
+25% +$104K ﹤0.01% 2725
2023
Q2 		$464K Buy
35,394
+3,916
+12% +$47.9K ﹤0.01% 2820
2023
Q1 		$352K Buy
31,478
+3,864
+14% +$38.1K ﹤0.01% 2930
2022
Q4 		$233K Buy
27,614
+6,229
+29% +$59.2K ﹤0.01% 3135
2022
Q3 		$356K Buy
21,385
+4,263
+25% +$78.5K ﹤0.01% 2999
2022
Q2 		$252K Buy
17,122
+1,445
+9% +$29.8K ﹤0.01% 3237
2022
Q1 		$390K Buy
15,677
+2,771
+21% +$71.6K ﹤0.01% 3106
2021
Q4 		$413K Buy
12,906
+528
+4% +$19.3K ﹤0.01% 3954
2021
Q3 		$446K Buy
12,378
+1,423
+13% +$56K ﹤0.01% 3876
2021
Q2 		$484K Buy
+10,955
New +$477K ﹤0.01% 3864
2021
Q1 		– Sell
-3,315
Closed -$229K – 4456
2020
Q4 		$229K Buy
+3,315
New +$162K ﹤0.01% 4056

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Credit Suisse's LUNG Position: Q1 2024 in Review

Credit Suisse increased its Pulmonx (LUNG) stake by 5.1% in Q1 2024, buying an estimated $27.3K and bringing the position to 48,127 shares worth $446K. The position accounts for ﹤0.01% of the portfolio, ranked #2684.

Credit Suisse first reported a position in LUNG in Q4 2020 and has held it in 13 quarters since. The position peaked at $584K in Q4 2023. 118 funds tracked by Wall St. Rank hold LUNG as of Q1 2024.

  • Credit Suisse held 48,127 shares of Pulmonx worth $446K as of Q1 2024.
  • Credit Suisse bought 2,331 Pulmonx shares in Q1 2024, an estimated $27.3K.
  • Pulmonx made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2684 holding.
  • Credit Suisse first reported a position in Pulmonx in Q4 2020 and has held it in 13 quarters since.
  • Credit Suisse's Pulmonx position peaked at $584K in Q4 2023.
  • 118 funds tracked by Wall St. Rank held Pulmonx as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.